GSK plc - Mar 27, 2025 Form SCHEDULE 13D/A Schedule Report for SPERO THERAPEUTICS, INC. (SPRO)

Filing Manager
GSK plc
Reporting Manager
GSK PLC
Security
SPERO THERAPEUTICS, INC. Common Stock, Par Value $0.001
Symbol
SPRO
Shares outstanding
56M shares
Disclosed Ownership
9.19M shares
Ownership
16.4%
Form type
SCHEDULE 13D/A
Date filed
3/28/2025, 04:30 PM
Date of event
Mar 27, 2025
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
GSK PLC 16.4% 9.19M 9.19M 0 /s/ Victoria A. Whyte Victoria A. Whyte / Authorized Signatory 0001131399